HLNE:NASDAQHamilton Lane Incorporated Analysis
Data as of 2026-04-08 - not real-time
$96.57
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hamilton Lane (HLNE) is trading at $96.57, well below its 20‑day, 50‑day and 200‑day moving averages, indicating a short‑term bearish technical backdrop. Despite the bearish price action, the MACD histogram is positive and the RSI sits near 40, suggesting early signs of momentum reversal. The stock’s DCF‑derived fair value of roughly $115 and an implied upside of over 60% contrast sharply with the current market price, flagging a material valuation gap. Fundamental metrics are robust: revenue grew 18% YoY, operating margins exceed 40%, and ROE stands at an impressive 32%, underscoring strong earnings power. The company generates ample cash, with free cash flow over $227 M and a modest net‑debt position, supporting a sustainable dividend yield of 2.2% and a payout ratio under 40%. Recent strategic news—partnering to launch a real‑world‑asset‑backed stablecoin—opens a new on‑chain credit avenue and adds a growth catalyst.
However, the stock exhibits elevated risk markers, including a 30‑day volatility above 40% and a beta of 1.4, which amplify price swings in a market currently in “Extreme Greed” mode. Volume trends are weakening, and the decreasing trading activity may impede short‑term price support. The asset‑management sector faces moderate regulatory and liquidity headwinds, but Hamilton Lane’s diversified global footprint keeps geographic risk low. The dividend appears sustainable given strong operating cash flow and conservative payout levels. With analysts averaging a “Buy” and target prices near $160, the upside potential remains compelling for medium‑to long‑term investors. In sum, the combination of deep valuation discount, high‑quality earnings, and emerging digital‑asset initiatives makes HLNE a candidate for accumulation, while short‑term caution is warranted.
However, the stock exhibits elevated risk markers, including a 30‑day volatility above 40% and a beta of 1.4, which amplify price swings in a market currently in “Extreme Greed” mode. Volume trends are weakening, and the decreasing trading activity may impede short‑term price support. The asset‑management sector faces moderate regulatory and liquidity headwinds, but Hamilton Lane’s diversified global footprint keeps geographic risk low. The dividend appears sustainable given strong operating cash flow and conservative payout levels. With analysts averaging a “Buy” and target prices near $160, the upside potential remains compelling for medium‑to long‑term investors. In sum, the combination of deep valuation discount, high‑quality earnings, and emerging digital‑asset initiatives makes HLNE a candidate for accumulation, while short‑term caution is warranted.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support level
- decreasing volume
- bullish MACD histogram
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- substantial valuation upside to DCF fair value
- strong earnings growth and high ROE
- tokenization partnership expanding revenue streams
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- long‑term target price near $160
- sustainable dividend yield
- diversified global platform and digital‑asset strategy
Key Metrics & Analysis
Financial Health
Revenue Growth18.00%
Profit Margin30.59%
P/E Ratio17.2
ROE31.70%
ROA10.86%
Debt/Equity27.95
P/B Ratio4.8
Op. Cash Flow$361.2M
Free Cash Flow$227.9M
Industry P/E16.8
Technical Analysis
TrendBearish
RSI40.5
Support$90.47
Resistance$105.97
MA 20$98.49
MA 50$112.99
MA 200$132.83
MACDBullish
VolumeDecreasing
Fear & Greed Index84.64
Valuation
Fair Value$114.83
Target Price$162.29
Upside/Downside68.05%
GradeUndervalued
TypeBlend
Dividend Yield2.24%
Risk Assessment
Beta1.43
Volatility41.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.